Use of scintigraphy with 99mtechnetium galactosyl human serum albumin for staging of primary biliary cirrhosis and assessment of prognosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 6, 1999, Pages 566-571

  Shiomi, Susumu ^a   Sasaki, Nobumitsu ^a   Tamori, Akihiro ^a   Habu, Daiki ^a   Takeda, Tadashi ^a   Nishiguchi, Shuhei ^a   Kuroki, Tetsuo ^a   Kawabe, Joji ^a   Ochi, Hironobu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Primary biliary cirrhosis; Prognosis; Staging

Indexed keywords

HUMAN SERUM ALBUMIN TC 99M; ASIALOGLYCOPROTEIN RECEPTOR; CELL SURFACE RECEPTOR; DIAGNOSTIC AGENT; MACROSALB TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M DTPA GALACTOSYL HUMAN SERUM ALBUMIN; TECHNETIUM TC 99M DTPA-GALACTOSYL-HUMAN SERUM ALBUMIN;

ADULT; ARTICLE; CHRONIC HEPATITIS; FEMALE; HEART; HUMAN; LABORATORY TEST; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PLASMA CLEARANCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; RADIOACTIVITY; SCINTIANGIOGRAPHY; STAGING; SURVIVAL; BILIARY CIRRHOSIS; HOSPITALIZATION; METABOLISM; MIDDLE AGED; SCINTISCANNING; STATISTICAL MODEL;

ASIALOGLYCOPROTEIN RECEPTOR; FEMALE; HUMANS; LINEAR MODELS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PROGNOSIS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RECEPTORS, CELL SURFACE; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 0032589125     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01923.x     Document Type: Article

References (20)

1. 1 Ahrens Jr EH, Payne MA, Kunkel HG, Eisenmenger WJ, Blondheim SH. Primary biliary cirrhosis. Medicine 1950; 29: 299-364.
2. 2 Roll J, Boyer JL, Barry D, Kiatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N. Engl. J. Med. 1983; 308: 1-7.
3. 3 Christensen E, Neuberger J, Crowe J et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: Final results of an international trial. Gastroenterology 1985; 89: 1084-91.
4. 4 Dickson ER, Gramabsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989; 10: 1-7.
5. 5 Inoue K, Hirohara J, Nakano T et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995; 15: 70-7.
6. 6 Stadalnik RC, Vera DR, Woodle ES et al. Technetium-99m NGA functional hepatic imaging: Preliminary clinical experience. J. Nucl. Med. 1985; 26: 1233-42.
7. 7 Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage. Am. J. Gastroenterol. 1992; 87: 865-70.
8. 8 Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau W. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labelled asialoglycoprotein analog. Hepatology 1994; 20: 917-23.
9. 9 Scheuer PJ. Primary biliary cirrhosis. Proc. R. Soc. Med. 1967; 60: 1257-60.
10. 10 Poupon R, Chretien Y, Poupon RE, Ballet F, Calmus Y, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; i: 834-6.
11. 11 Poupon RE, Poupon R, Balkau B, UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N. Engl. J. Med. 1994; 330: 1342-7.
12. 12 Shiomi S, Kuroki T, Kuriyama M et al. Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA. J. Nucl. Med. 1997; 38: 79-82.
13. 13 Hamlyn AN, Macklon AF, James O. Primary biliary cirrhosis: Geographical clustering and symptomatic onset seasonality. Gut 1983; 24: 940-5.
14. 14 Eriksson S, Lindgren S.The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand. J. Gastroenterol. 1984; 19: 971-6.
15. 15 Danielsson C, Boqvist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990; 11: 458-64.
16. 16 Wolke AM, Schaffner F, Kapelman B, Sacks HS. Malignancy in primary biliary cirrhosis: High incidence of breast cancer in affected women. Am. J. Med. 1984; 76: 1075-8.
17. 17 Klion FM, FabryTL, Palmer M, Schaffner F. Prediction of survival of patients with primary biliary cirrhosis: Examination of the Mayo clinic model on a group of patients with known endpoint. Gastroenterology 1992; 102: 310-13.
18. 18 Schrander-van der Meer AM, Vogten AJM. Estimation of survival probability in cirrhotics: Evaluation of a computer model applicable for decision-making. Neth. J. Med. 1992; 40: 183-9.
19. 19 Keeffe EB, Lieberman DA, Krishnamurthy S, Krishnamurthy GT, Gilbert SA. Primary biliary cirrhosis:Tc-99m IDA planar and SPECT scanning. Radiology 1988; 166: 143-8.
20. 20 Aburano T, Yokoyama K, Shuke N et al. The role of Tc-99m IDA hepatobiliary and Tc-99m colloid hepatic imaging in primary biliary cirrhosis. Clin. Nucl. Med. 1991; 16: 4-9.